Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients

Journal of Cancer Research and Clinical Oncology

Volumn 139, Issue 4, 2013, Pages 691-702

  Tunca, Berrin ^a   Tezcan, Gulcin ^a   Cecener, Gulsah ^a   Egeli, Unal ^a   Zorluoglu, Abdullah ^b   Yilmazlar, Tuncay ^a   Ak, Secil ^a   Yerci, Omer ^a   Ozturk, Ersin ^a   Umut, Gorkem ^a   Evrensel, Turkkan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

^b Acibadem Hospital   (Turkey)

Author keywords

CK20; Colorectal cancer; EIF5A; MAP3K8; Poor prognosis; Turkish population

Indexed keywords

INITIATION FACTOR 5A; INOSINATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CK20 GENE; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE FREE SURVIVAL; DNA DETERMINATION; EARLY CANCER; EUKARYOTIC TRANSLATION INITIATION FACTOR 5A GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMP INOSINE MONOPHOSPHATE DEHYDROGENASE GENE; MALE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 8 GENE; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SURVIVAL TIME; UNINDEXED SEQUENCE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; KERATIN-20; MALE; MAP KINASE KINASE KINASES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEPTIDE INITIATION FACTORS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84876414952     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1372-x     Document Type: Article

References (55)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR (1993) Clues to the pathogenesis of familial CRC. Science 260(5109):812-816
2. Ajao OG, Adenuga MO, Lapido JK (1988) Colorectal carcinoma in patients under the age of 30 years; a review of 11 cases. JR Coll Surg Edinb 33(5):277-279
3. Aparecida Alves C, Silva ID, Villanova FE, Nicolau SM, Custódio MA, Bortoletto C, Gonçalves WJ (2006) Differential gene expression profile reveals overexpression of MAP3K8 in invasive endometrioid carcinoma. Eur J Gynaecol Oncol 27(6):589-593
4. Atkin WS, Cuzick J, Northover JM, Whynes DK (1993) Prevention of CRC by once-only sigmoidoscopy. Lancet 341(8847):736-740
5. Beckman EN, Gathright JB, Ray JE (1984) A potentially brighter prognosis for colon carcinoma in the third and fourth decades. Cancer 54(7):1478-1481
6. Boardman LA (2009) Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of CRC. Genome Med 1(4):36
7. Brouwer C, Vermunt-de Koning DG, Trueworthy RC, Ter Riet PG, Duley JA, Trijbels FJ, Hoogerbrugge PM, Bokkerink JP, van Wering ER, De Abreu RA (2006) Monitoring of inosine monophosphate dehydrogenase activity in mononuclear cells of children with acute lymphoblastic leukemia: enzymological and clinical aspects. Pediatr Blood Cancer 46(4):434-438
8. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH (2000) Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119(2):431-440
9. Chen W, Luo JH, Hua WF, Zhou FJ, Lin MC, Kung HF, Zeng YX, Guan XY, Xie D (2009) Overexpression of EIF-5A2 is an independent predictor of outcome in patients of urothelial carcinoma of the bladder treated with radical cystectomy. Cancer Epidemiol Biomarkers Prev 18(2):400-408
10. Chiang JM, Chen MC, Changchien CR, Chen JS, Tang R, Wang JY, Yeh CY, Fan CW, Tsai WS (2003) Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age younger may be a distinct patient group. Dis Colon Rectum 46(7):904-910
11. Chung YF, Eu KW, Machin D, Ho JM, Nyam DC, Leong AF, Ho YH, Seaw-Choen F (1998) Young age is not a poor prognostic marker in CRC. Br J Surg 85(9):1255-1259
12. Das S, Cho J, Lambertz I, Kelliher MA, Eliopoulos AG, Du K, Tsichlis PN (2005) Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner. J Biol Chem 280(25):23748-23757
13. Dumitru CD, Ceci JD, Tsatsanis C, Kontoyiannis D, Stamatakis K, Lin JH, Patriotis C, Jenkins NA, Copeland NG, Kollias G, Tsichlis PN (2000) TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103(7):1071-1083
14. Fang Y, Guan X, Guo Y, Sham J, Deng M, Liang Q, Li H, Zhang H, Zhou H, Trent J (2001) Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 30(3):254-260
15. Fellenberg J, Bernd L, Delling G, Witte D, Zahlten-Hinguranage A (2007) Prognostic significance of drug-regulated genes in high-grade osteosarcoma. Mod Pathol 20(10):1085-1094
16. Forozan F, Mahlamäki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden GC, Ethier SP, Kallioniemi A, Kallioniemi OP (2000) Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res 60(16):4519-4525
17. Hall NR, Finan PJ, Ward B, Turner G, Bishop DT (1994) Genetic susceptibility to CRC in patients under 45 years of age. Br J Surg 81(10):1485-1489
18. Hanauske Abel HM, Park MH, Hanauske AR, Popowicz AM, Lalande M, Folk JE (1994) Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim Biophys Acta 1221(2):115-124
19. Harnden P, Mahmood N, Southgate J (1999) Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet 353(9157):974-977
20. He Y, Mou Z, Li W, Liu B, Fu T, Zhao S, Xiang D, Wu Y (2009) Identification of IMPDH2 as a tumor-associated antigen in CRC using immunoproteomics analysis. Int J Colorectal Dis 24(11):1271-1279
21. Isbister W (1992) CRC below age 40 in the Kingdom of Saudi Arabia. Aust NZ J Surg 62(6):468-472
22. Isbister WH, Fraser J (1990) Large bowel cancer in the young: a national survey study. Dis Colon Rectum 33(5):363-366
23. Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Podar K, Le Gouill S, Shiraishi N, Yasui H, Roccaro AM, Tai YZ, Chauhan D, Fram R, Tamura K, Jain J, Anderson KC (2005) Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway. Oncogene 24(38):5888-5896
24. Jeong JH, Bhatia A, Toth Z, Oh S, Inn KS, Liao CP, Roy-Burman P, Melamed J, Coetzee GA, Jung JU (2011) TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growth. PLoS ONE 6(1):e16205
25. Johannessen CM, Boehm JS, Kim SY et al (2010) COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 468(7326):968-972
26. Jovov B, Araujo-Perez F, Sigel CS, Stratford JK, McCoy AN, Yeh JJ, Keku T (2012) Differential gene expression between African American and European American CRC patients. PLoS ONE 7(1):e30168
27. Kang HA, Hershey JW (1994) Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem 269(6):3934-3940
28. Khanna N, Jayaram HN, Singh N (2004) Benzamide riboside induced mitochondrial mediated apoptosis in human lung cancer H520 cells. Life Sci 75(2):179-190
29. Knight RD, Mangum J, Lucas DL, Cooney DA, Khan EC, Wright DG (1987) Inosine monophosphate dehydrogenase and myeloid cell maturation. Blood 69(2):634-639
30. Krcova Z, Ehrmann J, Krejci V, Eliopoulos A, Kolar Z (2008) Tpl-2/Cot and COX-2 in breast cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152(1):21-25
31. Lassmann S, Bauer M, Rosenberg R, Nekarda H, Soong R, Rüger R, Höfler H, Werner M (2004) Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression. Int J Colorectal Dis 19(2):87-94
32. Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, Wang SM (2003) Clinicopathological and molecular biological features of CRC in patients less than 40 years of age. Br J Surg 90(2):205-214
33. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-D D C (T))method. Methods 25(4):402-408
34. Moll R, Löwe A, Laufer J, Franke WW (1992) Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140(2):427-447
35. Murphy WM (1990) Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 21(9):886-889
36. Nosho K, Yamamoto H, Adachi Y, Erdo Y, Hinoda Y, Imai K (2005) Gene expression profiling of colorectal adenomas and early invasive carcinomas by cDNA array analysis. Br J Cancer 92(7):1193-1200
37. Pack SD, Karkera JD, Zhuang Z, Pak ED, Balan KV, Hwu P, Park WS, Pham T, Ault DO, Glaser M, Liotta L, Detera-Wadleigh SD, Wadleigh RG (1999) Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 25(2):160-168
38. Park MH, Wolff EC, Folk JE (1993) Is hypusine essential for eukaryotic cell proliferation? Trends Biochem Sci 18(12):475-479
39. Park MH, Lee YB, Joe YA (1997) Hypusine is essential for eukaryotic cell proliferation. Biol Signals 6(3):115-123
40. Parramore JB, Wei JP, Yeh KA (1998) CRC in patients under forty: presentation and outcome. Am Surg 64(6):563-568
41. Penuelas S, Noe V, Ciudad CJ (2005) Modulation of IMPDH2, survivin, topoisomerase I and vimentin increases sensitivity to methotrexate in HT29 human colon cancer cells. FEBS J 272(3):696-710
42. Petersen I, Bujard M, Petersen S, Wolf G, Goeze A, Schwendel A, Langreck H, Gellert K, Reichel M, Just K, du Manoir S, Cremer T, Dietel M, Ried T (1997) Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res 57(12):2331-2335
43. Sattler HP, Rohde V, Bonkhoff H, Zwergel T, Wullich B (1999) Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer. Prostate 39(2):79-86
44. Sham JS, Tang TC, Fang Y, Sun L, Qin LX, Wu QL, Xie D, Guan XY (2003) Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women. Cancer Genet Cytogenet 133(1):39-44
45. Shi XP, Yin KC, Ahern J, Davis LJ, Stern AM, Waxman L (1996) Effects of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on the growth of tumorigenic cell lines in culture. Biochim Biophys Act 1310(1):119-126
46. Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, Hammam HM, El-Hattab OH, Kamal SM, Soliman AGA, Dorgham LA, McPherson S, Beasley P (1997) CRC in Egyptian patients under 40 years of age. Int J Cancer 71(1):26-30
47. Tatsumi N, Mukaisho K, Mitsufuji S, Tatsumi Y, Sugihara H, Okanoue T, Hattori T (2005) Expression of cytokeratins 7 and 20 in serrated adenoma and related diseases. Dig Dis Sci 50(9):1741-1746
48. Turkish Ministry of Health, (1999) http://www.saglik.gov.tr
49. Wildi S, Kleeff J, Maruyama H, Maurer CA, Friess H, Büchler MW, Lander AD, Korc M (1999) Characterization of cytokeratin 20 expression in pancreatic and CRC. Clin Cancer Res 5(10):2840-2847
50. Xie D, Ma NF, Pan ZZ, Wu HX, Liu YD, Wu GQ, Kung HF, Guan XY (2008) Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum Pathol 39(1):80-86
51. Yalowitz JA, Jayaram HN (2000) Molecular targets of guanine nucleotides in differentiation, proliferation and apoptosis. Anticancer Res 20(4):2329-2338
52. Yang GF, Xie D, Liu JH, Luo JH, Li LJ, Hua WF, Wu HM, Kung HF, Zeng YX, Guan XY (2009) Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma. Gynecol Oncol 112(2):314-318
53. Yilmazlar T, Zorluoglu A, Ozguc H, Korun N, Duman H, Kaya E, KIzIl A (1995) CRCs in young adults. Tumori 81(4):230-233
54. Zimmermann A, Gu JJ, Spychala J, Mitchell BS (1996) Inosine monophosphate dehydrogenase expression: transcriptional regulation of the type I and type II genes. Adv Enzyme Regul 36:75-84
55. Zorluoglu A, Yilmazlar T, Ozguc H, Bagcivan E, Guner O (2004) CRCs under 45 years of age. Hepatogastroenterology 51(55):118-120